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 Acute myocardial infarction (MI) with a normal coronary angiogram is a 
well-established abnormality, although it is usually related with stenosis in 
coronary arteries. We reported here a case of a 24-year-old man referring 
with acute inferior MI after MaxMan capsule consumption. The patient had 
not any related risk factors of coronary artery disease and a history of prior 
MI. The acute inferior infarction in this patient was detected in the 
electrocardiogram in the absence of any stenosis or obstruction in the 
angiogram. We do not recommend MaxMan intake as a usual drug before 
intercourse. 
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Introduction 
cute inferior myocardial infarction 
(MI) with normal angiography is 
explained in previous reports, 
however, the etiology and treatment of this 
medical condition is conflicting (1). In normal 
coronary angiography its prevalence range 
from 1% to 12% (2, 3). MaxMan is one such 
male enhancement product that increases 
blood flow and penis size. It contains a 
mixture of ginseng, Maca Powder, Guarana, 
Avena Sativa and Rowdy Weed (4). It was 
not approved by the Food and Drug 
Administration (FDA) and in 03-02-2015 the 
FDA declared that the consumption of MM2 
MaxMan is dangerous and must be avoided 
(5). We present a 24-year-old male patient 
with a diagnosed electrocardiographic MI 
without any previous cardiovascular risk 
factors with normal angiography. 
 
Case Report 
A 24-year-old man with chest pain and 
dyspnea referred to cardiology emergency 
department of Bushehr heart center hospital, 
Iran. The patient had no medical history of 
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hypertension, previous MI, diabetes mellitus, 
smoking, hypercholesterolemia or premature 
coronary artery disease (CAD), and family 
history of cardiovascular diseases. He has 
consumed MaxMan capsules as an erection 
enhancer agent before intercourse. The patient 
was admitted in the emergency ward because 
of severe chest pain, sweating, nausea, 
vomiting, and tachycardia 1 hour after 
MaxMan intake. On physical examination, 
blood pressure was within the normal range. 
The resting electrocardiogram (ECG) was 
performed for him, and the typical acute 
inferior MI was diagnosed in 12-lead ECG 
(Figure 1).  
 
 
Figure 1. Electrocardiogram at admission. Normal 
sinus rhythm, 2 mm ST depression II, III avf lead, 1 
mm ST depression I, II, avf lead, premature 
ventricular contraction multiple wave, II, III lead, 
axis normal, heart rate 60/min, acute infarction 
elevation myocardial infarction 
 
Laboratory tests including total serum 
cholesterol, high-density lipoprotein 
cholesterol, triglycerides, low-density 
lipoprotein cholesterol, fasting plasma 
glucose, and plasma homocysteine were in 
normal range. Then, the patient was treated 
using streptokinase 1.5 million IU during 1-
hour. 3 days after admission, coronary 
angiography was performed for the patient 
that was normal without any narrowing and 
culprit lesions (Figures 2 and 3).  
 
 
Figure 2. Normal angiography  
 
4 days after admission, the ECG was taken 
and the patient was discharged (Figure 4).  
 
 
Figure 3. Normal coronary artery 
 
Discussion 
As stated in this report, normal coronary 
angiography was reported in 1-12% of 
patients. The incidence of this condition is 
related to the definition of normality, sex, age, 
etc. (1-4). MaxMan is a penis enlargement 
agent, but the ingredients of this drug are 
unknown so, FDA has not improved it (5, 6).  
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Figure 4. Electrocardiogram at discharge. Heart 
rate 75/min, Q wave, II, III avf lead, 1 mm ST 
depression I, II, avf lead, 1 avl normal segment 
 
Based on the Australian Department of 
Health Therapeutic Goods Administration it 
is a fake drug containing undeclared 
ingredients, but the most important agent of 
MaxMan is sildenafil (5). We reported a  
24-year-old man with chest pain and dyspnea 
due to MaxMan capsule intake before 
intercourse. He showed the typical acute 
inferior MI in 12-lead ECG, but the 
angiography was normal. Patients with 
inferior MI without any stenosis in coronary 
angiography have a 3-7-year survival rate 
about 90%; moreover, the rate of reinfarction 
in these patients is lower than other CADs 
(7). In a case report in 2009 Iuliano et al. (8) 
reported a 49-year-old woman with a history 
of MI with a normal angiography. Moreover, 
another case report by Kim et al. (9) in 2009 
reported a 61-year-old man with ST-segment 
elevation in inferior leads, but normal 
angiogram in the right and left coronary 
arteries. As stated in this paper some of the 
patients affected by CAD have a normal 
angiogram and in a study in 2007 in the 
United States, 20% of 865 000 patients with 
coronary heart disease (CHD) symptoms have 
a normal angiogram (10). Therefore, the 
treatment and management of these patients 
are a matter of concern. In line with our 
findings, in this report, Iuliano et al. (8) 
indicated that the patients with CHD 
symptoms and normal angiogram are young 
and had good prognoses. Therefore, 
appropriate treatment of these patients can 
decrease adverse events and increase survival. 
In this report, the patient was evaluated based 
on diagnostic algorithm according to the 
AHA/ACC guidelines. Therefore, the 
diagnosis of MI based on ECG with normal 
coronary angiography raises an important 
question, concerning the application of 
AHA/ACC secondary prevention guidelines 
for MI. MaxMan is not approved by the US 
FDA with unknown ingredients so; it should 
be consumed more cautiously. 
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